Viewing Study NCT00576758


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:01 PM
Study NCT ID: NCT00576758
Status: COMPLETED
Last Update Posted: 2014-08-19
First Post: 2007-12-18
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma
Sponsor: Hoffmann-La Roche
Organization: